IBB

170.66

0.10% 0.17

After Hours: 170.40 -0.26 -0.15%

Ishares Biotechnology Etf (IBB)

Overview News Price History Option Chain Discussions Forecast Dividend History

Ishares Biotechnology Etf stock is traded at $170.66, with a volume of 1.71M. It is up +0.10% in the last 24 hours and down -0.94% over the past month.

Previous Close:

$170.49

Open:

$170.72

24h Volume:

1.71M

Relative Volume:

1.14

Market Cap:

$9.09B

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+1.32%

1M Performance:

-0.94%

6M Performance:

+0.73%

1Y Performance:

+32.29%

1-Day Range:

$169.98

$172.28

1-Week Range:

$165.88

$172.28

52-Week Range:

$123.61

$179.64

Ishares Biotechnology Etf Stock (IBB) Company Profile

Name

Ishares Biotechnology Etf

Sector

Financial (5932)

Industry

Exchange Traded Fund (4504)

Phone

Address

Employee

Twitter

@iShares

Next Earnings Date

Latest SEC Filings

IBB's Discussions on Twitter

Compare IBB vs VTI, SPY, IVV, VB, QQQ

Stocks	Price	Market Cap
IBB Ishares Biotechnology Etf	170.66	9.09B
VTI Vanguard Total Stock Market Etf	366.36	417.53B
SPY Spdr S P 500 Etf Trust	741.75	372.57B
IVV Ishares Core S P 500 Etf	745.14	253.41B
VB Vanguard Small Cap Etf	296.38	160.59B
QQQ Invesco Qqq Trust Series 1	721.34	124.43B

Ishares Biotechnology Etf Stock (IBB) Latest News

Jun 10, 2026

Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market - TradingView

Jun 10, 2026

Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - Yahoo Finance

Jun 10, 2026

Jun 05, 2026

Sector Update: Healthcare Stocks Gain Friday Afternoon - Moomoo

Jun 05, 2026

Sector Update: Healthcare - Moomoo

Jun 05, 2026

BioCardia Jumps After FDA Feedback Seen Positive for CardiAMP Approval - TechStock²

Jun 05, 2026

Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Friday After May Jobs Report - Moomoo

Jun 05, 2026

Flow Focus | Marvell Ripped, Broadcom Cracked — AI Money Is Getting Pickier - Moomoo

Jun 05, 2026

Jun 04, 2026

Stock Market Today: Nasdaq 100 Slips As Broadcom Plunges, Bitcoin Hits 4-Month Lows - Benzinga

Jun 04, 2026

Recursion Stock Jumps Before Goldman Sachs Event as AI-Drug Trade Gets Fresh Heat - TechStock²

Jun 04, 2026

Alnylam Eyes Faster Drug Discovery With AI Partnership Worth Up To $2 Billion - Benzinga

Jun 04, 2026

Sector Update: Healthcare Stocks Rise Premarket Thursday - Moomoo

Jun 04, 2026

Jun 03, 2026

Tectonic Therapeutic Stock Climbs as Broader Market Sinks - Bez Kabli

Jun 03, 2026

Kyverna Therapeutics Stock Barely Moves—The Bigger CAR-T Test Is Coming - Bez Kabli

Jun 03, 2026

Design Therapeutics Drops Ahead of Jefferies, Trial Remains in Focus for DSGN - Bez Kabli

Jun 02, 2026

Ligand Shares Hold Up in Biotech Rout While XOMA Deal Heads for Investor Vote - Bez Kabli

Jun 02, 2026

Legend Biotech Stock Jumps on Full Response in Small Trial as Traders React Quickly - TechStock²

Jun 02, 2026

VivoSim Stock Sits Near 52-Week Low, Biotech Faces Pre-Market Cash Crunch - Bez Kabli

Jun 02, 2026

Jun 01, 2026

Healthcare Stocks Slipped As Biotech Took A Beating - Finimize

Jun 01, 2026

Healthcare Stocks Slipped As A Cancer Screening Trial Disappointed - Finimize

Jun 01, 2026

May 29, 2026

Celcuity Rises Ahead of ASCO Update With FDA Deadline Pressing - Bez Kabli

May 29, 2026

Zai Lab Shares Slide 4.27% as Biotech Sector Faces HeadwindsLow Risk Entry Stocks - thelegaladvocate.com

May 29, 2026

Orchestra BioMed Shares Trade Lower Ahead of Trial Milestone - Bez Kabli

May 29, 2026

May 28, 2026

Vaxcyte Inc. (PCVX) Slips 1.4% as Shares Test Key Support ZoneAdaptive Moving Average - thelegaladvocate.com

May 28, 2026

May 27, 2026

Daily ETF Flows: NVDL In Demand - ETF.com

May 27, 2026

May 26, 2026